Motor neuron disease/amyotrophic lateral sclerosis
Frontostriatal deficit in Motor Neuron Disease/Amyotrophic Lateral Sclerosis (MND/ALS)
... reported: Motor Neuron Disease/Amyotrophic Lateral Sclerosis/Dementia Syndrome (MND/ALS/DS) and Motor Neuron Disease/Amyotrophic Lateral ...
6
Frequency and risk factor analysis of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease
... Objectives: To examine the frequency and risk factors of cognitive and anxiety-depressive disorders in patients with amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). ...
8
The use of full setting non invasive ventilation in the home care of people with amyotrophic lateral sclerosis motor neuron disease with end stage respiratory muscle failure: a case series
... of amyotrophic lateral sclerosis-motor neuron disease patients with end-stage respiratory muscle ...home-based amyotrophic lateral sclerosis-motor ...
6
Sharing and empathy in digital spaces: qualitative study of online health forums for breast cancer and motor neuron disease. (Amyotrophic Lateral Sclerosis)
... The availability of an increasing number of online health forums has altered the experience of living with a health condition because more people are now able to connect and support one another [1]. This relatively ...
22
Amyotrophic lateral sclerosis motor neuron disease, monoclonal gammopathy, hyperparathyroidism, and B12 deficiency: case report and review of the literature
... lower motor neuron syndrome with preserved reflexes in at least one limb in three patients, and motor neuropathy with multifocal conduction block in one ...upper motor neuron ...
7
Evaluating a novel cervical orthosis, the Sheffield Support Snood, in patients with amyotrophic lateral sclerosis/motor neuron disease with neck weakness
... The project illustrates the value of including patients and their family carers in the design process, with use and performance improvements over current neck orthoses and a sense of ownership among research ...
19
Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort
... Consecutive patients in whom the treating neurologist felt had a likely diagnosis of ALS/MND were invited to participate in the national registry. ALS/MND care deliv- ery in Australia is through 10 major clinics and the ...
7
Evaluating a novel cervical orthosis, the Sheffield Support Snood, in patients with amyotrophic lateral sclerosis/motor neuron disease with neck weakness
... Severe weakness of the neck extensor muscles has been described in various neuromuscular disorders including myasthenia gravis, spinal muscular atrophy and amyotrophic lateral sclerosis (ALS) / ...
21
Focus on the Role of D-serine and D-amino Acid Oxidase in Amyotrophic Lateral Sclerosis/Motor Neuron Disease (ALS)
... The finding of a mutation in DAO, which is transmitted with disease offered the opportunity to elucidate pathogenic disease mechanisms caused by the mutation. Indeed, both D-serine and DAO, are strongly ...
7
Dominantly Inherited Amyotrophic Lateral Sclerosis (Motor Neuron Disease)
... The term amyotrophic lateral sclerosis (ALS) was first introduced by Charcot to describe cases with mixed upper and lower motor neuron signs without.. This is paper #46 f[r] ...
5
Establishing the UK DNA Bank for motor neuron disease (MND)
... of disease prognosis, patients must have experienced symptom onset (significant muscle weakness) on or after January ...definite Amyotrophic Lateral Sclerosis (ALS) ...Primary Lateral ...
9
A blended psychosocial support program for partners of patients with amyotrophic lateral sclerosis and progressive muscular atrophy: protocol of a randomized controlled trial
... of motor neuron disease, research studies on PMA caregivers are ...the disease progresses, ALS caregivers experience heightened feel- ings of psychological distress and burden [6 – 8], which ...
11
Original Article Anesthetic strategy for percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis patients
... Abstract: Amyotrophic Lateral Sclerosis (ALS) is a kind of severe and lethal motor neuron disease, its clinical symp- tom including dysphasia, choking, cough, acataposis and ...
6
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice
... Motor neuron diseases (MND) are a group of diverse neurological disorders with motor neuron involvement that include amyotrophic lateral sclerosis (ALS), pri- mary ...
16
Advanced magnetic resonance neuroimaging in bulbar and limb onset early amyotrophic lateral sclerosis.
... Introduction: Amyotrophic lateral sclerosis (ALS) is a fatal and most common motor neuron disease, caused by progressive loss of motor ...the disease, which may ...
7
Caregiving in ALS A mixed methods approach to the study of Burden
... Keywords: Caregiver, Burden, Dimensions, Difficulties, Wellbeing, Amyotrophic lateral sclerosis, Motor neuron disease, Ireland, Mixed methods research Abbreviations: ALS, amyotrophic lat[r] ...
12
Stigma, perceived control and health related quality of life for individuals experiencing Parkinson’s disease
... Huntington’s disease (HD), motor neuron disease (MND)/amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) often produce visible symptoms, such as ...
343
Clinical Reasoning: A 42-year-old man with unilateral leg weakness
... the motor neuron, the nerve, and the ...of motor neuron disease, such as familial amyotrophic lateral sclerosis ...lower motor neuron pattern would ...
7
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
... Abstract: Amyotrophic lateral sclerosis (ALS) is the commonest form of motor neuron disease and is a fatal, degenerative, multisystem disorder affecting upper and/or lower ...
10
Astrocyte adenosine deaminase loss increases motor neuron toxicity in amyotrophic lateral sclerosis
... or disease pathology conditions, ATP derived adenosine levels increase significantly and can activate low affinity receptors (A2b) (Dunwiddie and Masino, ...astrocyte-mediated motor neuron toxicity in ...
21